LYEL
Price
$22.71
Change
+$0.07 (+0.31%)
Updated
Feb 6 closing price
Capitalization
482.66M
Intraday BUY SELL Signals
ZNTL
Price
$2.39
Change
+$0.18 (+8.14%)
Updated
Feb 6 closing price
Capitalization
154.75M
24 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LYEL vs ZNTL

Header iconLYEL vs ZNTL Comparison
Open Charts LYEL vs ZNTLBanner chart's image
Lyell Immunopharma
Price$22.71
Change+$0.07 (+0.31%)
Volume$124.59K
Capitalization482.66M
Zentalis Pharmaceuticals
Price$2.39
Change+$0.18 (+8.14%)
Volume$841.94K
Capitalization154.75M
LYEL vs ZNTL Comparison Chart in %
LYEL
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LYEL vs. ZNTL commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (LYEL: $22.71 vs. ZNTL: $2.39)
Brand notoriety: LYEL and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 117% vs. ZNTL: 52%
Market capitalization -- LYEL: $482.66M vs. ZNTL: $154.75M
LYEL [@Biotechnology] is valued at $482.66M. ZNTL’s [@Biotechnology] market capitalization is $154.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 0 green, 5 red.
According to our system of comparison, both LYEL and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 4 TA indicator(s) are bullish while ZNTL’s TA Score has 5 bullish TA indicator(s).

  • LYEL’s TA Score: 4 bullish, 6 bearish.
  • ZNTL’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а -5.38% price change this week, while ZNTL (@Biotechnology) price change was -1.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LYEL($483M) has a higher market cap than ZNTL($155M). ZNTL YTD gains are higher at: 77.037 vs. LYEL (-26.218). ZNTL has higher annual earnings (EBITDA): -152.83M vs. LYEL (-188.82M). LYEL has more cash in the bank: 320M vs. ZNTL (281M). ZNTL has less debt than LYEL: ZNTL (36.7M) vs LYEL (44.3M). ZNTL has higher revenues than LYEL: ZNTL (26.9M) vs LYEL (41K).
LYELZNTLLYEL / ZNTL
Capitalization483M155M312%
EBITDA-188.82M-152.83M124%
Gain YTD-26.21877.037-34%
P/E RatioN/AN/A-
Revenue41K26.9M0%
Total Cash320M281M114%
Total Debt44.3M36.7M121%
FUNDAMENTALS RATINGS
ZNTL: Fundamental Ratings
ZNTL
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELZNTL
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FZAMX27.050.77
+2.93%
Fidelity Advisor Mid Cap II Z
HRCIX69.221.67
+2.47%
Carillon ClariVest Capital Apprec I
PMYTX50.400.97
+1.96%
Putnam Core Equity Fund R6
FDVKX12.960.18
+1.41%
Fidelity Value Discovery K6
TISDX12.40N/A
N/A
Transamerica Intl Sust Eq A

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+0.31%
VCYT - LYEL
46%
Loosely correlated
+3.82%
TYRA - LYEL
44%
Loosely correlated
+5.23%
OLMA - LYEL
42%
Loosely correlated
+1.40%
ERAS - LYEL
41%
Loosely correlated
+3.45%
ZNTL - LYEL
40%
Loosely correlated
+8.14%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+8.14%
IMVT - ZNTL
59%
Loosely correlated
+12.43%
IMNM - ZNTL
58%
Loosely correlated
+3.67%
TRDA - ZNTL
58%
Loosely correlated
+5.26%
SYRE - ZNTL
57%
Loosely correlated
+6.62%
IPSC - ZNTL
56%
Loosely correlated
+1.80%
More